If you liked this article you might like

Spark's Hemophilia Gene Therapy Remains Effective Despite Immune Reactions
The Great 'ASH16' Abstract Drop Mostly Causes Drug Stocks to Do Same
Jim Cramer's Top Takeaways: Spark Therapeutics, General Mills, Kellogg, ConAgra, Campbell
Jim Cramer's 'Mad Money' Recap: This Market Has a One-Track Mind